Drugs / NP-101
NP-101
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT06217094 | Feb 2026 → Jul 2028 | hepatocellular carcinoma | University of Florida | Withdrawn | No outcome recorded Stop: Business |
| Phase 1 | NCT06563375 | Mar 2025 → Sep 2028 expected | cancer | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
| Phase 1 | NCT05262556 | Dec 2022 → Dec 2025 overdue | digestive system neuroendocrine neoplasm, neuroendocrine carcinoma | Amr Mohamed MD | Active not recruiting | No outcome recorded |
| Phase 1 | NCT04914767 | Mar → Oct 2021 | COVID-19 | Hôpital Universitaire Sahloul | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05785390 | Feb 2023 → May 2025 | COVID-19 | Novatek Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NP-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06563375 ↗ |
| Known as | black seed | “Nigella (known as black seed) in the Latin language or "Habatulbarakah" in the Arabic language, is a food supplement and a medicinal plant well known in Arab and Islamic culture.” NCT04914767 ↗ |
| Known as | Habatulbarakah | “Nigella (known as black seed) in the Latin language or "Habatulbarakah" in the Arabic language, is a food supplement and a medicinal plant well known in Arab and Islamic culture.” NCT04914767 ↗ |
| Known as | Nigella | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04914767 ↗ |
| Known as | Nigella seed oil | “Nigella seed oil is suggested as a potential supplement due to its known immunostimulatory and antiviral activities in previous published studies.” NCT04914767 ↗ |
| Known as | TQ Formula | “NP-101 (TQ Formula) (TQ, C10H12O2) is the main bioactive component of the black seed (Nigella sativa, Ranunculaceae family) and has anti-oxidant, anti-angiogenic effects.” NCT05262556 ↗1“The rationale behind NP-101 (TQ formula) stems from its immune modulatory properties as a potent drug derived from a natural substance, black seed or Nigella Sativa.” NCT06217094 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “is a food supplement and a medicinal plant” NCT04914767 ↗ |
| Route | Oral | “From the fourth day, the patient will take one capsule, three times a day for 12 days.” NCT04914767 ↗ |